Veracyte Income Statement (2012-2026) | VCYT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	60.37M	67.34M	67.78M	72.86M	75.59M	80.30M	82.42M	90.32M	90.11M	98.20M	96.84M	114.43M	115.86M	118.63M	114.47M	130.16M	131.87M	140.64M	139.07M	150.32M
Cost of Revenue (Quarter)	4.08M	1.58M	17.52M	18.58M	4.21M	19.39M	2.16M	23.33M	21.83M	8.41M	1.26M	1.87M	3.11M	6.67M	0.11M	3.57M	33.78M	1.45M	1.89M	36.31M
Gross Profit (Quarter)	56.29M	65.75M	50.26M	54.28M	71.38M	60.90M	80.26M	55.82M	57.69M	64.79M	62.47M	77.91M	79.01M	78.75M	79.51M	89.77M	91.28M	101.97M	101.16M	108.55M
Operating items
Amortization - Intangibles (Quarter)	5.00M	5.48M	5.49M	5.39M	5.21M	3.17M	5.33M	4.81M	4.81M	4.04M	2.92M	2.91M	2.92M	2.81M	2.58M	2.67M	2.71M	2.71M	2.71M	2.74M
Research & Development (Quarter)	8.01M	10.25M	9.17M	24.00M	25.68M	68.24M	26.13M	25.76M	13.32M	18.67M	15.96M	24.22M	22.61M	45.43M	24.45M	25.32M	15.98M	20.85M	27.10M	29.44M
Selling, General & Administrative (Quarter)	20.75M	18.85M	20.91M	19.80M	17.60M	18.21M	21.05M	25.05M	16.33M	23.80M	26.21M	31.75M	25.74M	26.91M	33.81M	32.33M	27.28M	17.37M	23.68M	27.44M
Other Operating Expenses (Quarter)	48.30M	50.57M	52.95M	39.80M	41.99M	-121.59M	45.74M	13.07M	59.77M	57.83M	24.95M	17.35M	18.64M	2.24M	18.34M	37.39M	25.08M	26.56M	27.73M	28.68M
Operating Expenses (Quarter)	77.05M	79.67M	83.03M	83.60M	85.27M	-35.14M	92.92M	63.87M	89.43M	100.30M	67.12M	73.31M	66.99M	74.58M	76.60M	95.04M	68.34M	64.78M	78.51M	85.57M
Operating Income (Quarter)	-16.68M	-12.33M	-15.25M	-10.73M	-9.68M	-5.42M	-10.50M	-8.05M	-31.74M	-35.51M	-4.66M	4.61M	12.02M	4.17M	2.90M	-5.27M	22.95M	37.20M	22.65M	22.98M
EBIT (Quarter)	-16.68M	-12.33M	-15.25M	-10.73M	-9.68M	-5.42M	-10.50M	-8.05M	-31.74M	-35.51M	-4.66M	4.61M	12.02M	4.17M	2.90M	-5.27M	22.95M	37.20M	22.65M	22.98M
Non-operating items
Other Non Operating Income (Quarter)	1.20M	1.02M	0.78M	1.09M	0.81M	1.98M	2.41M	-0.23M	1.97M	5.04M	2.75M	2.75M	4.83M	-0.73M	4.52M	6.52M	-4.06M	3.44M	7.33M	3.54M
Net income details
EBT (Quarter)	-15.48M	-11.32M	-14.46M	-9.65M	-8.88M	-3.44M	-8.09M	-8.28M	-29.77M	-30.46M	-1.91M	7.36M	16.85M	3.40M	7.43M	1.25M	18.89M	40.63M	29.97M	26.52M
Tax Provisions (Quarter)	-1.35M	-0.79M	-0.00M	-0.12M	-0.15M	0.37M		0.10M	-0.20M	-2.18M	-0.04M	1.60M	1.69M	-1.67M	0.40M	2.23M	-0.20M	-0.56M	1.27M	1.03M
Profit After Tax (Quarter)	-14.13M	-10.53M	-14.46M	-9.53M	-8.72M	-3.84M	-8.09M	-8.40M	-29.62M	-28.29M	-1.86M	5.73M	15.15M	5.11M	7.05M	-0.98M	19.14M	41.15M	28.71M	25.49M
Income from Continuing Operations (Quarter)	-14.13M	-10.53M	-14.46M	-9.53M	-8.72M	-3.81M	-8.09M	-8.38M	-29.57M	-28.28M	-1.86M	5.76M	15.15M	5.07M	7.03M	-0.98M	19.09M	41.20M	28.71M	25.49M
Consolidated Net Income (Quarter)	-14.13M	-10.53M	-14.46M	-9.53M	-8.72M	-3.81M	-8.09M	-8.38M	-29.57M	-28.28M	-1.86M	5.76M	15.15M	5.07M	7.03M	-0.98M	19.09M	41.20M	28.71M	25.49M
Income towards Parent Company (Quarter)	-14.13M	-10.53M	-14.46M	-9.53M	-8.72M	-3.81M	-8.09M	-8.38M	-29.57M	-28.28M	-1.86M	5.76M	15.15M	5.07M	7.03M	-0.98M	19.09M	41.20M	28.71M	25.49M
Net Income towards Common Stockholders (Quarter)	-14.13M	-10.53M	-14.46M	-9.53M	-8.72M	-3.81M	-8.09M	-8.38M	-29.57M	-28.28M	-1.86M	5.76M	15.15M	5.07M	7.03M	-0.98M	19.09M	41.20M	28.71M	25.49M
Additional items
EPS (Basic) (Quarter)	-0.20	-0.16	-0.20	-0.13	-0.12	-0.05	-0.11	-0.12	-0.41	-0.39	-0.02	0.08	0.20	0.07	0.09	-0.01	0.24	0.52	0.36	0.32
EPS (Diluted) (Quarter)	-0.20	-0.16	-0.20	-0.13	-0.12	-0.05	-0.11	-0.12	-0.41	-0.39	-0.02	0.07	0.19	0.06	0.09	-0.01	0.24	0.51	0.35	0.31
Shares Outstanding (Quarter)	69.74M	67.89M	71.23M	71.48M	71.66M	71.55M	72.18M	72.48M	72.80M	72.64M	74.76M	76.54M	77.01M	76.48M	78.03M	78.39M	78.73M	78.58M	79.54M	79.97M
Shares Outstanding (Diluted) (Quarter)	69.74M	67.89M	71.23M	71.48M	71.66M	71.55M	72.18M	72.48M	72.80M	72.64M	74.76M	77.16M	78.47M	78.16M	80.06M	78.39M	79.69M	80.57M	81.31M	82.06M
Shares Outstanding (Entity) (Quarter)	71.03M	71.12M	71.43M	71.56M	71.74M	71.96M	72.38M	72.64M	72.99M	73.26M	76.43M	76.74M	77.49M	77.77M	78.31M	78.60M	79.03M	79.36M	79.79M	80.36M
EBITDA (Quarter)	-16.68M	-12.33M	-15.25M	-10.73M	-9.68M	-5.42M	-10.50M	-8.05M	-31.74M	-35.51M	-4.66M	4.61M	12.02M	4.17M	2.90M	-5.27M	22.95M	37.20M	22.65M	22.98M
Interest Expenses (Quarter)	21.68M		18.84M	18.17M	17.90M	-3.35M	17.75M	17.74M	14.50M	1.46M	12.17M	12.17M	12.17M	1.90M	12.03M	92.53M	74.68M	1.88M	11.71M	71.15M
Tax Rate (Quarter)	8.72%	6.95%	0.02%	1.19%	1.71%	-10.75%		-1.21%	0.67%	7.15%	2.31%	21.74%	10.05%	-49.13%	5.39%	178.40%	-1.06%	-1.39%	4.23%	3.89%

Research Tools

Developers

Veracyte Income Statement (2012-2026) | VCYT

Research Tools

Developers

Veracyte Income Statement (2012-2026) | VCYT

Create an account

Sign In

Reset Password